OXBRIDGE RE HOLDINGS Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OXBRIDGE RE HOLDINGS Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.58M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $546.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($7.05M) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $850.0K | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $10.23M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | $1.21M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $981.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $3.80M | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | $23.84M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $19.06M | Mar 13, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.08M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($2.73M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($9.92M) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($1.79M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $8.57M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | ($50.0K) | Mar 30, 2022 |
| FY2019 | Dec 31, 2019 | $61.0K | Mar 23, 2020 |
| FY2019 | Sep 30, 2019 | ($15.0K) | Mar 23, 2020 |
| FY2019 | Jun 30, 2019 | ($205.0K) | Mar 23, 2020 |
| FY2019 | Mar 31, 2019 | ($146.0K) | Mar 23, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.35M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($284.0K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($1.26M) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($829.0K) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($253.0K) | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | ($266.0K) | Mar 30, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $5.0K | Mar 26, 2025 |
| FY2022 | Dec 31, 2021 | $3.0K | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | $14.0K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $1.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $0 | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | $6.0K | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $11.0K | Mar 13, 2018 |
| FY2016 | Dec 31, 2015 | $36.0K | Mar 13, 2017 |
| FY2015 | Dec 31, 2014 | $59.0K | Mar 17, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.05M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $7.47M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $8.25M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $16.62M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $17.69M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | $9.08M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $9.50M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $12.56M | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | $21.39M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $51.00M | Mar 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.62M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $2.92M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.63M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $1.04M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | $1.06M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $1.45M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $4.25M | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | $7.48M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $13.84M | Mar 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.92M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $3.95M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $5.33M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $14.99M | Mar 26, 2024 |
| FY2023 | Dec 31, 2021 | $16.65M | Mar 26, 2024 |
| FY2022 | Dec 31, 2020 | $8.03M | Mar 30, 2023 |
| FY2022 | Dec 31, 2019 | $8.04M | Mar 30, 2022 |
| FY2019 | Sep 30, 2019 | $7.97M | Mar 23, 2020 |
| FY2019 | Jun 30, 2019 | $7.98M | Mar 23, 2020 |
| FY2019 | Mar 31, 2019 | $8.18M | Mar 23, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($32.14M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($30.16M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($27.41M) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($17.50M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($15.71M) | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | ($24.28M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($24.23M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($23.92M) | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | ($18.15M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $4.53M | Mar 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $268.0K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $2.14M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $495.0K | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.21M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $3.53M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | $5.56M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $5.96M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $8.07M | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | $7.76M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $12.24M | Mar 13, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | (1) | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | (3) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | (1) | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | (3) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 13, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.66M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 6.38M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 5.87M | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | 5.77M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 5.75M | Mar 30, 2023 |
| FY2022 | Dec 31, 2020 | 5.73M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 5.73M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 5.73M | Mar 23, 2020 |
| FY2018 | Dec 31, 2017 | 5.92M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | 5.92M | Mar 13, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Mar 19, 2019 |
| FY2018 | Dec 31, 2017 | $2.09M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $2.89M | Mar 13, 2018 |
| FY2016 | Dec 31, 2015 | $2.91M | Mar 13, 2017 |
| FY2015 | Dec 31, 2014 | $1.71M | Mar 17, 2016 |